The metabolic response to targeted medications, such as for example imatinib in gastrointestinal stromal tumor (GIST) patients, may appear in the first hours after treatment begins and will be used to regulate a patient’s daily dosage (Hughes et al

The metabolic response to targeted medications, such as for example imatinib in gastrointestinal stromal tumor (GIST) patients, may appear in the first hours after treatment begins and will be used…